Frequently asked questions
The global intraocular lens market was valued at USD 3,9 Billion in 2022.
The intraocular lens market is expected to grow at a CAGR of 5.60% between 2023 and 2030, reaching USD 5.7 Billion in 2030.
Monofocal intraocular lens is the leading segment by type, holding over 43% share in terms of value in 2022.
The hydrophobic and hydrophilic acrylic materials segment governs the demand for intraocular lenses in the world, holding a massive share of over 80% in 2022.
The ophthalmology clinics segment is expected to post the fastest growth during the forecast period.
North America is fueling the growth of the intraocular lens industry, with over one-third share in 2022.
The top players include Rayner Intraocular Lens Ltd, Johnson & Johnson, Alcon, Humanoptics, Bausch Health Inc., EyeKon Medical Inc, Carl Zeiss Meditech, Lenstec Inc., Hoya Corporation
The increase in demand for these cataract operations, technical developments, and supportive government efforts are the major market drivers.
The major market restraints include the unfavorable reimbursement environment for premium lenses and postoperative issues, including refractive errors.
Technology advancements in intraocular lenses are the major opportunities in the industry.